# Effectiveness of Ketamine in Malignant Neuropathic Pain Relief

> **NCT01951911** · PHASE3 · WITHDRAWN · sponsor: **Haukeland University Hospital**

## Conditions studied

- Pain, Intractable

## Interventions

- **DRUG:** Ketamine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01951911
- **Lead sponsor:** Haukeland University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2013-09
- **Primary completion:** 2016-10
- **Final completion:** 2016-10
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Poor patient recruitment. Vast majority of the patients have exclusions criteria
- **Last updated:** 2017-07-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01951911

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01951911, "Effectiveness of Ketamine in Malignant Neuropathic Pain Relief". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01951911. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*